Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cell lines (LCLs) are used to prepare human EBV-specific T lymphocytes (EBV-CTL) in vitro. Within an LCL, up to 5-7% the cells release infectious EBV, and this has fostered safety concerns for therapeutic applications because of the exposure of T cells to EBV. The release of infectious viruses can be prevented by ganciclovir, but this drug may seriously affect LCL growth. In the wake of these concerns, the present work was designed to compile safety data on EBV-CTL preparation for the purpose of submission to a regulatory agency. We showed that further to supernatant exclusion, the number of EBV genome copies (EBVc) associated with the EBV-CTL always made up a constant proportion of the EBVc number detected in the culture supernatant. In addition, such was the case whether infectious virus could be produced by the LCL or not, suggesting that the EBV signal detected was due to a DNA contamination rather than an infection. Furthermore, we demonstrated that the number of EBVc associated with the EBV-CTL was highly sensitive to DNAse treatment, and finally that EBVc could no longer be detected after the EBV-CTL had been amplified in the absence of LCL. Consequently, during in vitro EBV-CTL preparation, either T cells cannot be infected or they die rapidly after EBV infection.
Berthomé
Mathilde
M
Institut de Recherche Thérapeutique de l'Université de Nantes, UMR INSERM, U892, 8 quai Moncousu, BP 70721, 44007, Nantes Cedex 1, France.
Gallot
Géraldine
G
Vivien
Régine
R
Clémenceau
Béatrice
B
Nguyen
Jean-Michel
JM
Coste-Burel
Marianne
M
Vié
Henri
H
D001402:B-Lymphocytes / Q000821:virology*; D002460:Cell Line; D004279:DNA, Viral / Q000097:blood*; D015774:Ganciclovir / Q000494:pharmacology; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000821:virology*
D004279:DNA, Viral; D015774:Ganciclovir
Blood. 2010 Feb 4;115(5):925-35
19880495
Am J Med. 1982 Jul 20;73(1A):18-26
6285710
Blood. 2001 Sep 15;98(6):1882-8
11535525
Blood. 1997 Jun 15;89(12):4521-30
9192776
J Exp Med. 1991 Apr 1;173(4):971-80
1706754
J Virol. 1980 May;34(2):560-8
6246281
Cancer Immunol Immunother. 2002 Nov;51(10):539-46
12384805
Nature. 1988 Jun 2;333(6172):455-7
2836734
Eur J Haematol. 2007 Jul;79(1):72-5
17532761
Proc Natl Acad Sci U S A. 1974 Mar;71(3):863-6
4274561
J Immunol. 1995 Feb 1;154(3):1440-9
7822809
Clin Chem. 1999 Jul;45(7):982-6
10388473
Semin Cancer Biol. 1996 Aug;7(4):197-207
8946604
J Med Virol. 2009 Jan;81(1):90-8
19031462
Blood. 2000 Jul 15;96(2):443-51
10887104
Anticancer Res. 1999 Jul-Aug;19(4B):3007-17
10652585
Blood. 1992 Oct 1;80(7):1804-12
1327284
J Immunol. 1991 Feb 1;146(3):865-9
1703182
J Infect Dis. 2001 Jan 1;183(1):1-7
11106535
J Virol. 1996 Oct;70(10):7341-6
8794395
Eur J Immunol. 1988 Aug;18(8):1299-302
2970972
J Clin Invest. 1993 Sep;92(3):1444-50
8397226
Pediatr Blood Cancer. 2009 Aug;53(2):184-90
19353621
Leuk Lymphoma. 1999 May;33(5-6):451-8
10342573
J Virol. 1984 Apr;50(1):50-5
6321799
Hum Gene Ther. 2000 Jul 1;11(10):1453-63
10910142
J Clin Pathol. 2007 Jan;60(1):101-3
17213357
Hum Gene Ther. 2000 Jul 1;11(10):1465-75
10910143
Blood. 1995 Jan 15;85(2):456-64
7811999
Blood. 1991 Feb 15;77(4):799-808
1847084
J Immunol. 1998 Jun 15;160(12):6204-9
9637540
Cell Immunol. 1979 Jun;45(1):157-66
313274
Expert Opin Biol Ther. 2008 Sep;8(9):1265-94
18694349
Blood. 1993 Jul 1;82(1):217-23
8391874
J Clin Microbiol. 2000 Feb;38(2):712-5
10655372
Blood. 1993 May 15;81(10):2688-95
8387835
J Virol. 1990 Jan;64(1):437-44
2152830
Am J Pathol. 1994 Jun;144(6):1219-25
8203462
J Gen Virol. 1989 May;70 ( Pt 5):1203-15
2543775
N Engl J Med. 1995 Oct 19;333(16):1038-44
7675046
Am J Pathol. 1990 May;136(5):1093-9
2161617
Lancet. 1990 Jan 20;335(8682):128-30
1967431
J Gen Virol. 1990 Feb;71 ( Pt 2):379-86
2155291
Cytotherapy. 2003;5(4):323-35
12944239